A detailed history of Sg Americas Securities, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 158,921 shares of BCRX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158,921
Holding current value
$1.21 Million
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$6.41 - $8.69 $1.02 Million - $1.38 Million
158,921 New
158,921 $1.21 Million
Q1 2024

May 06, 2024

SELL
$4.89 - $7.65 $257,580 - $402,963
-52,675 Reduced 79.54%
13,548 $69,000
Q4 2023

Jan 12, 2024

BUY
$4.98 - $6.77 $329,790 - $448,329
66,223 New
66,223 $397,000
Q4 2022

Feb 02, 2023

SELL
$10.5 - $14.2 $90,730 - $122,702
-8,641 Reduced 40.32%
12,791 $147,000
Q3 2022

Oct 31, 2022

SELL
$10.79 - $14.81 $667,361 - $915,998
-61,850 Reduced 74.27%
21,432 $270,000
Q2 2022

Jul 29, 2022

SELL
$7.89 - $17.88 $1.21 Million - $2.75 Million
-153,563 Reduced 64.84%
83,282 $881,000
Q1 2022

Apr 29, 2022

SELL
$11.56 - $19.76 $339,517 - $580,351
-29,370 Reduced 11.03%
236,845 $3.85 Million
Q4 2021

Feb 07, 2022

SELL
$11.18 - $15.46 $762,062 - $1.05 Million
-68,163 Reduced 20.39%
266,215 $3.69 Million
Q3 2021

Nov 01, 2021

BUY
$14.21 - $17.65 $4.61 Million - $5.72 Million
324,142 Added 3166.69%
334,378 $4.81 Million
Q2 2021

Aug 12, 2021

SELL
$9.5 - $17.24 $553,821 - $1.01 Million
-58,297 Reduced 85.06%
10,236 $162,000
Q1 2021

May 13, 2021

BUY
$7.37 - $13.61 $77,001 - $142,197
10,448 Added 17.99%
68,533 $697,000
Q4 2020

Feb 04, 2021

SELL
$3.37 - $8.61 $515,562 - $1.32 Million
-152,986 Reduced 72.48%
58,085 $433,000
Q3 2020

Nov 09, 2020

SELL
$3.43 - $5.53 $2.48 Million - $4 Million
-723,877 Reduced 77.42%
211,071 $725,000
Q2 2020

Jul 20, 2020

BUY
$1.9 - $5.61 $1.66 Million - $4.9 Million
872,602 Added 1399.61%
934,948 $4.46 Million
Q1 2020

Apr 30, 2020

BUY
$1.6 - $4.11 $67,433 - $173,220
42,146 Added 208.64%
62,346 $125,000
Q4 2019

Jan 28, 2020

BUY
$1.59 - $3.45 $32,118 - $69,690
20,200 New
20,200 $70,000
Q2 2019

Jul 29, 2019

SELL
$2.91 - $9.15 $60,365 - $189,807
-20,744 Closed
0 $0
Q1 2019

Apr 29, 2019

BUY
$7.38 - $9.72 $153,090 - $201,631
20,744 New
20,744 $169,000
Q4 2017

Jan 24, 2018

SELL
$4.16 - $5.33 $112,278 - $143,856
-26,990 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$4.1 - $5.97 $110,658 - $161,130
26,990
26,990 $141,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.